Blaha M - Search Results

1

Optimization of the therapeutic procedure during LDL-apheresis--a computerized model.

Blaha M, Masin V, Stransky P, Blaha V, Cermanova M, Maly J, Belada D. Blaha M, et al. Among authors: blaha v. Transfus Apher Sci. 2005 Apr;32(2):149-56. doi: 10.1016/j.transci.2004.10.022. Transfus Apher Sci. 2005. PMID: 15784449

2

Activity of thrombocytes as a marker of sufficient intensity of LDL-apheresis in familial hypercholesterolaemia.

Blaha M, Pecka M, Urbankova J, Blaha V, Maly J, Zadak Z, Blazek M. Blaha M, et al. Among authors: blaha v. Transfus Apher Sci. 2004 Apr;30(2):83-7. doi: 10.1016/j.transci.2003.11.002. Transfus Apher Sci. 2004. PMID: 15062743

3

Optimization of therapeutic procedure during LDL-apheresis - verification of the computerized model in clinical practice.

Masin V, Blaha M, Stransky P, Blaha V, Cermanova M, Maly R, Zajic J. Masin V, et al. Among authors: blaha v, blaha m. Transfus Apher Sci. 2007 Feb;36(1):39-45. doi: 10.1016/j.transci.2006.10.004. Epub 2007 Feb 9. Transfus Apher Sci. 2007. PMID: 17292673

4

Safety and tolerability of long lasting LDL-apheresis in familial hyperlipoproteinemia.

Bláha M, Cermanová M, Bláha V, Blazek M, Malý J, Siroký O, Solichová D, Filip S, Rehácek V. Bláha M, et al. Among authors: blaha v. Ther Apher Dial. 2007 Feb;11(1):9-15. doi: 10.1111/j.1744-9987.2007.00450.x. Ther Apher Dial. 2007. PMID: 17309569

5

Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia.

Blaha M, Cermanova M, Blaha V, Jarolim P, Andrys C, Blazek M, Maly J, Smolej L, Zajic J, Masin V, Zimova R, Rehacek V. Blaha M, et al. Among authors: blaha v. Atherosclerosis. 2008 Mar;197(1):264-70. doi: 10.1016/j.atherosclerosis.2007.04.022. Epub 2007 May 30. Atherosclerosis. 2008. PMID: 17540382 Clinical Trial.

6

WAA apheresis registry in the Czech Republic: two centers experience.

Bláha M, Pták J, Cáp J, Ceeová V, Masín V, Filip S, Blazek M. Bláha M, et al. Transfus Apher Sci. 2009 Aug;41(1):27-31. doi: 10.1016/j.transci.2009.05.005. Epub 2009 Jun 12. Transfus Apher Sci. 2009. PMID: 19524488

7

Experience with extracorporeal elimination therapy in myasthenia gravis.

Blaha M, Pitha J, Blaha V, Lanska M, Maly J, Filip S, Brndiar M, Langrova H. Blaha M, et al. Among authors: blaha v. Transfus Apher Sci. 2011 Dec;45(3):251-6. doi: 10.1016/j.transci.2011.10.003. Epub 2011 Oct 20. Transfus Apher Sci. 2011. PMID: 22018894

8

Primary hemostasis in patients treated with LDL-apheresis for severe familiar hypercholesterolemia: a prospective pilot trial using PFA-100 analysis to rationalize therapeutic LDL-apheresis procedure.

Blazek M, Blaha M, Pecka M, Blaha V, Masin V, Maly J. Blazek M, et al. Among authors: blaha v, blaha m. Hematology. 2007 Dec;12(6):571-6. doi: 10.1080/10245330701448370. Hematology. 2007. PMID: 17852459

9

The importance of rheological parameters in the therapy of the dry form of age-related macular degeneration with rheohaemapheresis.

Bláha M, Rencová E, Langrová H, Lánská M, Bláha V, Studnička J, Rozsíval P, Malý R, Fátorová I, Filip S, Dršata J, Hejsek L, Malý J. Bláha M, et al. Among authors: blaha v. Clin Hemorheol Microcirc. 2012;50(4):245-55. doi: 10.3233/CH-2011-1431. Clin Hemorheol Microcirc. 2012. PMID: 22240359 Clinical Trial.

10

Beneficial effect of plasma exchange in the treatment of toxic epidermal necrolysis: a series of four cases.

Koštál M, Bláha M, Lánská M, Koštálová M, Bláha V, Štepánová E, Malý J. Koštál M, et al. Among authors: blaha v, blaha m. J Clin Apher. 2012;27(4):215-20. doi: 10.1002/jca.21213. Epub 2012 Mar 10. J Clin Apher. 2012. PMID: 22407895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,190 results

Search Page

Filters